Lithium tablets are taken by mouth for long-term mood stabilisation in adults with bipolar disorder. Treatment aims to reduce manic episodes and prevent future mood episodes through effects on…
Lithium tablets are taken by mouth for long-term mood stabilisation in adults with bipolar disorder. Treatment aims to reduce manic episodes and prevent future mood episodes through effects on intracellular signalling in the brain.
Lithium is a prescription psychiatric medication and a foundational Mood Stabilizer, also spelled Mood Stabiliser in Irish and UK clinical materials. It is used mainly for long-term maintenance therapy and prophylaxis of bipolar disorders. Its role is to reduce the recurrence and severity of manic, depressive, or mixed mood episodes over time.
Lithium compounds are mineral-derived salts that release lithium ions after oral administration. Clinical treatment uses pharmaceutical lithium salts rather than a general nutritional supplement. The exact salt and release pattern determine how the tablet is absorbed and monitored.
NICE guidance places lithium among the principal options for preventing relapse when the person can undergo regular blood, kidney, and thyroid monitoring [1].
Pharmaceutical treatment uses lithium salts. Lithium Carbonate, lithium citrate, and other lithium salts release lithium ions, but they are not automatically interchangeable on a tablet-for-tablet basis. The amount of elemental lithium supplied by a salt depends on its chemical structure.
Lithium carbonate is written chemically as Li₂CO₃. Some products use immediate-release tablets, while others use modified-release or sustained-release tablets. The absorption pattern, dosing schedule, and instructions for missed doses can differ between these formulations.
The tablets sold as Lithium should be used according to the individual regimen established for that formulation. Do not substitute lithium carbonate, lithium citrate, lithium orotate, or another lithium compound without a prescriber’s direction.
| Lithium form | Clinical consideration | Practical implication |
|---|---|---|
| Lithium carbonate | Established pharmaceutical lithium salt | Requires prescribed dosing and serum monitoring |
| Other pharmaceutical lithium salts | May differ in elemental lithium content and absorption | Conversion requires clinical supervision |
| Lithium orotate and non-prescription preparations | Do not have an interchangeable clinical dosing system | They should not replace prescribed lithium |
Lithium is absorbed through the gastrointestinal tract and is eliminated mainly by the kidneys. It is not extensively metabolised by the liver. The kidneys handle lithium in a way that is closely linked to sodium processing.
Immediate-release and sustained-release tablets can produce different concentration patterns. A sustained-release tablet must not be crushed or chewed unless the product-specific instructions explicitly permit it, because altering the tablet can change the release pattern and increase adverse effects.
Lithium is most closely associated with bipolar disorder, where it can help reduce excessive mood elevation, impulsivity, agitation, and recurrent episodes. It may also lower the risk of suicide in some people with long-term mood disorders, although the treatment decision depends on the individual clinical picture.
Lithium can be suitable when long-term prevention is the main treatment goal. It may be less suitable when a person cannot attend regular blood tests or has significant kidney, thyroid, cardiac, or fluid-balance problems.
Lithium tablets are taken by mouth for long-term mood stabilisation in adults with bipolar disorder. The dose is decided individually according to age, other medicines, kidney function, thyroid status, and general health.
Lithium dosage is decided individually, taking age, other medicines, kidney function, thyroid health, cardiac history, hydration, and previous response into account. The aim is to find a serum concentration that supports mood stability without producing toxicity.
A lithium blood sample is commonly timed about 12 hours after the previous dose. The same timing should be used as consistently as possible, because a sample taken soon after a dose may appear higher and can mislead dose adjustment.
Blood monitoring is more frequent when treatment begins, after a dose change, after a formulation change, during illness, or when another medicine is added. Once the regimen is stable, testing continues at intervals determined by the prescriber and local clinical practice.
A missed blood test can delay safe dose adjustment. A missed lithium dose should not be replaced with an extra dose unless a prescriber gives that instruction.
Lithium is not suitable for everyone. This medication is not for you if a clinician has identified a contraindication such as:
Medicines that may raise lithium concentrations include non-steroidal anti-inflammatory drugs, thiazide-type diuretics, loop diuretics, and some blood-pressure medicines that affect the renin–angiotensin system.
Lithium is not for you if you cannot attend regular blood tests or if you have significant kidney, thyroid, cardiac, or fluid-balance problems. It requires extra caution in older adults, people with epilepsy, people with low body-fluid reserves, and those taking medicines that affect kidney function or sodium balance. Tell the prescriber about over-the-counter painkillers, herbal products, and supplements before treatment changes.
Common adverse effects can include thirst, increased urination, fine hand tremor, nausea, loose stools, fatigue, and mild cognitive slowing. Some people notice these effects early and find that they lessen after the body adapts. Persistent symptoms still deserve review because they may indicate that the concentration or formulation needs adjustment.
Longer-term treatment can affect the thyroid, kidneys, parathyroid function, body weight, or skin. Acne and worsening of psoriasis can occur in some patients. A fine tremor is different from severe shaking with confusion, poor coordination, or slurred speech.
Lithium toxicity can cause:
Severe symptoms require urgent medical assessment. Do not take another lithium dose until an urgent clinician has assessed the situation.
The kidneys reabsorb lithium in a way that resembles sodium handling. When the body loses sodium or water, the kidneys may retain more lithium. This can raise the serum concentration even when the tablet dose has not changed.
Risk increases with fever, intense exercise in hot conditions, prolonged sweating, vomiting, diarrhoea, fasting, or a sudden low-salt diet. Diuretics, non-steroidal anti-inflammatory medicines, and medicines that affect the renin–angiotensin system can also raise lithium levels.
Lithium can interact with antipsychotics and antidepressants. Combined treatment may be clinically appropriate, but it can increase the need for observation because of additive neurological effects, tremor, sedation, or serotonin-related symptoms with selected antidepressant combinations.
Lithium enters nerve cells and influences intracellular signalling rather than acting as a simple sedative. It affects enzymes involved in second messenger systems, including pathways linked to inositol recycling and glycogen synthase kinase-3. These changes can alter how neurons respond to incoming signals.
The result is a gradual stabilising effect on networks involved in mood, motivation, sleep, and impulse control. Lithium does not simply block one neurotransmitter. Its action develops through several cellular processes, which helps explain why the clinical benefit usually builds over time.
Dopamine is one of the neurotransmitters involved in mania, reward processing, attention, and psychomotor activity. Lithium can moderate signalling downstream from dopamine receptors, helping reduce excessive neural activation without functioning as a direct dopamine-blocking antipsychotic.
Magnesium participates in many enzyme reactions and neuronal signalling processes. Zinc also influences synaptic communication and receptor activity. These minerals are relevant to neuroscience, but taking extra Magnesium or Zinc does not reproduce lithium treatment and should not be used to adjust mood without a specific clinical reason.
Lithium also affects glutamate, gamma-aminobutyric acid, serotonin, and other signalling networks. No single pathway explains its entire therapeutic action. The European Medicines Agency describes lithium treatment as requiring careful clinical follow-up because the beneficial concentration lies relatively close to the concentration associated with toxicity [2].
Several practical mistakes can reduce treatment stability or increase risk:
One easily missed detail is the timing of a blood test. A result without the last-dose time may be difficult to interpret, especially after a formulation or schedule change.
Lithium has a different role from antipsychotics and antidepressants. Antipsychotics often act more quickly during acute mania or severe agitation. Antidepressants may target depressive symptoms, but they require careful use in bipolar disorder because some people can develop mood elevation or rapid cycling.
| Treatment category | Main strength | Main limitation |
|---|---|---|
| Lithium Mood Stabilizer | Long-term relapse prevention with established maintenance use | Requires blood monitoring and attention to kidney, thyroid, fluid, and salt balance |
| Atypical antipsychotic | Often useful when mania, agitation, or psychotic symptoms need rapid control | May cause sedation, metabolic effects, movement symptoms, or cardiac effects |
| Antidepressant | May help selected depressive symptoms | Can destabilise mood in some people with bipolar disorder and is rarely used alone |
Lithium carbonate is a pharmaceutical salt with established clinical use. Lithium orotate does not provide a clinically interchangeable dosing system, and elemental lithium content cannot be inferred safely from a supplement label alone. These products should not be treated as equivalent.
Clinicians may choose lithium when long-term prevention is the central goal and the person can attend monitoring. An antipsychotic may be preferred for acute mania, psychosis, or severe behavioural disturbance. An antidepressant may be considered only within a broader bipolar treatment plan.
In clinical practice, doctors often view lithium as a treatment that rewards regular monitoring rather than rapid symptom chasing. The goal is not to increase the dose whenever a difficult day occurs. The goal is a stable concentration that fits the person’s kidney function, mood pattern, daily routine, and other medicines.
Psychiatrists also look for changes in sleep, speech, spending, irritability, impulsivity, and activity. Family observations can help identify early mania when the person feels unusually well and may not recognise the change themselves.
A prescriber may review the treatment after a new diagnosis, a manic episode, pregnancy planning, a significant illness, or a change in kidney or thyroid results. Lithium treatment is usually a continuing clinical process, not a short course that can be adjusted casually.
Lithium can cause dizziness, drowsiness, blurred vision, tremor, or slowed coordination, especially when treatment begins or the concentration becomes too high. The HPRA advises caution with activities requiring alertness when a medicine affects the central nervous system; this principle remains relevant in 2026. Do not drive or operate machinery while experiencing impaired concentration, poor coordination, severe tremor, or confusion.
Lithium may be prescribed to some adolescents by specialist psychiatric services, but use under 18 requires careful assessment and monitoring. NICE guidance published in 2014 and updated subsequently describes specialist involvement for bipolar disorder in younger people. Kidney function, thyroid status, growth, hydration, adherence, and family support all influence the treatment plan.
A fine hand tremor is a recognised adverse effect of lithium and can appear after treatment starts or after a concentration rises. The WHO pharmacovigilance framework published in 2018 supports treating a new or worsening tremor as clinically relevant when it occurs with gastrointestinal symptoms, weakness, confusion, or poor coordination. A marked tremor or tremor with neurological symptoms requires urgent assessment rather than self-adjustment.
Lithium can begin influencing acute mood symptoms before full maintenance benefit develops, but long-term prevention usually requires consistent treatment over time. The British Association for Psychopharmacology guideline published in 2016 describes lithium as a treatment requiring serum monitoring and ongoing review rather than an immediate symptom-relief medicine. The exact response depends on the episode, the chosen formulation, the blood concentration, and other treatments used.
Older adults may receive lithium, but they often need more cautious dosing and closer monitoring. Age-related changes in kidney function, lower body-fluid reserves, and multiple medicines can increase the risk of toxicity. The Royal College of Psychiatrists' 2023 guidance recommends careful review of renal function, hydration, cognition, falls risk, and interacting medicines when lithium is used later in life.
Do not take an extra tablet to compensate unless a prescriber specifically instructs you to do so. If the missed dose is noticed close to the next scheduled dose, the usual clinical approach is to avoid doubling and seek advice based on the timing and formulation. The NHS lithium safety information updated in 2024 stresses consistent dosing and urgent assessment when missed treatment is accompanied by toxicity symptoms or illness.
A steady fluid intake, a stable pattern of dietary salt, regular sleep, and moderation during exercise can support consistent lithium handling. Heavy sweating, prolonged fasting, dehydration, crash dieting, vomiting, and diarrhoea can increase risk by changing sodium or water balance. The EMA lithium safety information published in 2024 links fluid and electrolyte changes with altered lithium concentrations, so strenuous activity in hot weather deserves extra attention.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Based on 3 reviews
After several weeks, my mood swings became less disruptive and my sleep settled. I disliked the thirst at first, and I had to become more organised about blood tests. The tremor was mild but noticeable when holding a cup.
Several weeks 4 Nov 2026Lithium reduced the severe highs over the first few months, but the early nausea made breakfast difficult. My clinician adjusted the timing and checked my level after another medicine was added. I still needed regular kidney and thyroid tests.
The first few months 9 Oct 2026I missed a dose and nearly doubled the next one because I thought it would catch me up. The clinic told me not to do that. My main problem had been forgetting the same evening dose, so I started using a written routine.
23 Oct 2026
